These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 16081467

  • 21. Structural analysis of disease-causing mutations in the P-subfamily of forkhead transcription factors.
    Banerjee-Basu S, Baxevanis AD.
    Proteins; 2004 Mar 01; 54(4):639-47. PubMed ID: 14997560
    [Abstract] [Full Text] [Related]

  • 22. Lymphedema-distichiasis and FOXC2 gene mutations.
    Erickson RP.
    Lymphology; 2001 Mar 01; 34(1):1. PubMed ID: 11307659
    [No Abstract] [Full Text] [Related]

  • 23. Transcription factor FOXC2 demarcates the jugular lymphangiogenic region in avian embryos.
    Rutscher K, Wilting J.
    Lymphology; 2008 Mar 01; 41(1):11-7. PubMed ID: 18581954
    [Abstract] [Full Text] [Related]

  • 24. Human p32 is a novel FOXC1-interacting protein that regulates FOXC1 transcriptional activity in ocular cells.
    Huang L, Chi J, Berry FB, Footz TK, Sharp MW, Walter MA.
    Invest Ophthalmol Vis Sci; 2008 Dec 01; 49(12):5243-9. PubMed ID: 18676636
    [Abstract] [Full Text] [Related]

  • 25. Missense mutations of human homeoboxes: A review.
    D'Elia AV, Tell G, Paron I, Pellizzari L, Lonigro R, Damante G.
    Hum Mutat; 2001 Nov 01; 18(5):361-74. PubMed ID: 11668629
    [Abstract] [Full Text] [Related]

  • 26. Novel FOXC2 Mutation and Distichiasis in a Patient With Lymphedema-Distichiasis Syndrome.
    De Niear MA, Breazzano MP, Mawn LA.
    Ophthalmic Plast Reconstr Surg; 2018 Nov 01; 34(3):e88-e90. PubMed ID: 29406328
    [Abstract] [Full Text] [Related]

  • 27. Clinical and genetic study of 46 Italian patients with primary lymphedema.
    Michelini S, Degiorgio D, Cestari M, Corda D, Ricci M, Cardone M, Mander A, Famoso L, Contini E, Serrani R, Pinelli L, Cecchin S, Bertelli M.
    Lymphology; 2012 Mar 01; 45(1):3-12. PubMed ID: 22768468
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. FOXC2 truncating mutation in distichiasis, lymphedema, and cleft palate.
    Bahuau M, Houdayer C, Tredano M, Soupre V, Couderc R, Vazquez MP.
    Clin Genet; 2002 Dec 01; 62(6):470-3. PubMed ID: 12485195
    [Abstract] [Full Text] [Related]

  • 32. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia.
    Irrthum A, Devriendt K, Chitayat D, Matthijs G, Glade C, Steijlen PM, Fryns JP, Van Steensel MA, Vikkula M.
    Am J Hum Genet; 2003 Jun 01; 72(6):1470-8. PubMed ID: 12740761
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis.
    Petrova TV, Karpanen T, Norrmén C, Mellor R, Tamakoshi T, Finegold D, Ferrell R, Kerjaschki D, Mortimer P, Ylä-Herttuala S, Miura N, Alitalo K.
    Nat Med; 2004 Sep 01; 10(9):974-81. PubMed ID: 15322537
    [Abstract] [Full Text] [Related]

  • 35. Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations.
    Erickson RP, Dagenais SL, Caulder MS, Downs CA, Herman G, Jones MC, Kerstjens-Frederikse WS, Lidral AC, McDonald M, Nelson CC, Witte M, Glover TW.
    J Med Genet; 2001 Nov 01; 38(11):761-6. PubMed ID: 11694548
    [Abstract] [Full Text] [Related]

  • 36. Genetic landscape of FOXC2 mutations in lymphedema-distichiasis syndrome: Different mechanism of pathogenicity for mutations in different domains.
    Jiang L, Ren W, Xie C, Duan S, Dai C, Wei Y, Luo D, Wang T, Gong B, Liu X, Yang Z, Ye Z, Chen H, Shi Y.
    Exp Eye Res; 2022 Sep 01; 222():109136. PubMed ID: 35716761
    [Abstract] [Full Text] [Related]

  • 37. Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants.
    Greenblatt MS, Beaudet JG, Gump JR, Godin KS, Trombley L, Koh J, Bond JP.
    Oncogene; 2003 Feb 27; 22(8):1150-63. PubMed ID: 12606942
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.